In the News
Stability testing of protein therapeutics using dynamic light scattering
John Bak and Eric Olson explain how dynamic light scattering presents a good analytical technique for testing protein stability.
PPD, Clinical Ink join on lupus assessment and endpoint data
Carol Olson comments on how the two companies have partnered to develop a systemic lupus erythematosus assessment review to streamline clinical trials.
Bacterial endotoxins testing of water-insoluble drug substances by means of dispersion with dimethyl sulfoxide
The authors demonstrate a technique for sample preparation in which the drug substance is dissolved in dimethyl sulfoxide, followed by dilution in water.
US Army taps PPD to conduct PTSD treatment research
PPD receives five-year award to test the effectiveness and safety of pharmacotherapeutic drug candidates for the treatment of PTSD in U.S. military active duty personnel and veterans.
PPD pens Clinical Ink collab for new lupus trial platform
The companies jointly developed a systemic lupus erythematosus (SLE) assessment review process to simplify operationalizing clinical trials for the chronic autoimmune disease.
Advantages of developing and deploying an in-house regulatory intelligence
Sean Schofield, William Waggoner and John Joines write about the processes and considerations for developing and maintaining an in-house regulatory intelligence database.
Fulfilling a great promise
Evidera’s Jonca Bull comments on how cell and gene therapies hold such great promise, despite being among the most complex clinical trials in terms of design and execution.
Embracing a functional service partnership model for rapidly growing biotechs
Jan-Maarten Kroodsma and Timothy King discuss how a tailored functional service partnership model can provide expertise and flexibility for biotechnology companies.
How to address—and overcome—operational challenges in master protocol studies
PPD experts discuss how the critical need for COVID-19 therapeutics has helped to underscore an ongoing urgent need for more innovative clinical designs.
